Thyroid Cancer Awareness Month: What You Need to Know

For Thyroid Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.
BY Jessica Skarzynski
PUBLISHED September 21, 2019
For Thyroid Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space:


 
  1. After it produced a 75% overall response rate across a range of tumor types, including thyroid cancer, Vitrakvi was approved by the Food and Drug Administration for the treatment of patients with NTRK fusions.
  2. Instead of undergoing surgery for potential cancer, many people with thyroid nodules can safely opt for surveillance.
  3. One patient shared her story about why she thinks her thyroid cancer diagnosis happened for a reason.
  4. For Nicole McGuinness, timing was everything when a friend told her a surgeon from nearly 500 miles away was looking for her after spotting a lump on her neck that turned out to be thyroid cancer – when he saw her on the HGTV show “Beachfront Bargain Hunt.”
  5. The first anaplastic thyroid cancer drug in 50 years was approved earlier this year – learn more about it in this roundup of the biggest rare cancer updates from the American Society of Clinical Oncology.
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the Thyroid Cancer CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In